NIMENRIX
NIMENRIX
Approved
DIN Number
02402904
Drug Class
Human
Market Date
Aug 22, 2013
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02402904
AIG Number0554131001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07AH04 MENINGOCOCCUS, A, C, Y, W-135, TETRAVAL. PURIFIED POLYSACC. ANTIGEN
Product Specifications
Dosage FormPowder For Solution
,
Kit
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (5)
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP AActive
Strength: 5 MCG / 0.5 ML
Monograph: MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP CActive
Strength: 5 MCG / 0.5 ML
Monograph: MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135Active
Strength: 5 MCG / 0.5 ML
Monograph: MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP YActive
Strength: 5 MCG / 0.5 ML
Monograph: MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y
TETANUS TOXOIDActive
Strength: 44 MCG / 0.5 ML
Monograph: TETANUS TOXOID